Mynvax

Developer of novel recombinant vaccines to fight the human influenza virus and COVID19

placeBengaluru, Karnataka, India calendar_todayFounded 2017 groups29 employees language mynvax.com

Registered entities

Innovation

4 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 33 times.

YearFilings
20221
20232
20243
20251
20262

Investor mix

74 investors on record; lead investors include Array, Array, Array, Accel.

Investor typeCountShare
Venture capital34%
Private equity11%
Angel & family office11%
Accelerator & incubator11%
Other / undisclosed6892%
Coming soon